Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1988;11:491-494

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujimura, A.
Right arrow Articles by Ebihara, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujimura, A.
Right arrow Articles by Ebihara, A.

Hypertension, Vol 11, 491-494, Copyright © 1988 by American Heart Association


ARTICLES

Role of angiotensin II in renal prostaglandin E2 production after furosemide administration

A Fujimura and A Ebihara
Department of Clinical Pharmacology, Oita Medical School, Japan.

The role of plasma angiotensin II (Ang II) in furosemide-stimulated renal prostaglandin E2 (PGE2) production was evaluated in eight healthy subjects. Urine was collected for 60 minutes after furosemide administration (20 mg i.v.) with or without captopril pretreatment, and urinary excretion of PGE2, sodium, and furosemide was determined. Plasma renin activity (PRA) and Ang II were also measured before and 60 minutes after furosemide administration. Urinary PGE2 excretion, PRA, and Ang II increased after furosemide administration without captopril pretreatment, and there was a significant correlation between the increment in Ang II and that in urinary PGE2 excretion. Urinary PGE2 excretion and Ang II did not increase after furosemide administration with captopril pretreatment. Urine volume and urinary excretion of sodium and furosemide were not influenced by captopril pretreatment. These results suggest that Ang II may play an important role in furosemide-stimulated PGE2 production.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Q. Yan, X. Yang, A. Cantone, G. Giebisch, S. Hebert, and T. Wang
Female ROMK null mice manifest more severe Bartter II phenotype on renal function and higher PGE2 production
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R997 - R1004.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
N E Moghal and M Shenoy
Furosemide and acute kidney injury in neonates
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2008; 93(4): F313 - F316.
[Abstract] [Full Text] [PDF]